Wednesday, February 10, 2010, 8:01pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Qiagen NV (QGEN)

At 5:00AM SGT: 20.60 USD   0.00 (0.00%)  
 MORE ON QGEN 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Qiagen N.V. (NasdaqNM:QGEN) Delayed quote dataEdit
Last Trade:20.60 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:20.60
Open:N/A
Bid:20.97 x 200
Ask:21.02 x 1000
1y Target Est:24.28
Day's Range:N/A - N/A
52wk Range:14.32 - 23.71
Volume:0
Avg Vol (3m):1,265,240
Market Cap:4.76B
P/E (ttm):35.70
EPS (ttm):0.58
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add QGEN to Portfolio   Download Data

 HEADLINES 
•UPDATE - Qiagen profit beats estimate on demand for tests
at Reuters (Tue 5:02am)
•QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results
GlobeNewswire (Tue 5:00am)
•QIAGEN Acquires Exclusive Licence for Key PI3K gene
PR Newswire (Tue 5:00am)
•Q4 2009 Qiagen N.V. Earnings Release - Time Not Supplied
CCBN (Mon, Feb 8)
•QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
Business Wire (Fri, Feb 5)
•Incubators Spawn Ideas, Money for IBM, AOL
at TheStreet.com (Wed, Feb 3)
•Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Fourth Quarter and Year-End 2009 Financial Results Call Set for February 9
PR Newswire (Tue, Feb 2)
•Molecular Diagnostics Industry Creates New Sector With High Growth And Rapid Valuation Formation Characteristics For Investors According To Industry Expert
Wall Street Transcript (Wed, Jan 27)
•Genomic Testing Systems Create Sustainable Competitive Advantage For Selected Medical Diagnostic Stocks According To Award Winning Equity Analyst
Wall Street Transcript (Tue, Jan 26)
•QIAGEN Acquires ESE GmbH
PR Newswire (Tue, Jan 12)
More Headlines for QGEN...
 ANALYST 
EPS Est (next year) (Dec-09) :0.88
EPS Est (in 2 years) (Dec-10) :0.98
Avg Rec (current)*:2.1
PEG Ratio:1.41
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Qiagen N.V. provides technologies and products for preanalytical sample preparation and linked molecular assay solutions worldwide. Its sample technologies are used to collect, stabilize, isolate, and purify deoxyribonucleic acid (DNA), ribonuclei...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices